Active, not recruiting
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
NCT06433557
- Conditions
- Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +5 more
- Locations
-
- Ascendis Pharma Investigational Site Copenhagen, Denmark
- Ascendis Pharma Investigational Site Dublin, Ireland
- Ascendis Pharma Investigational Site London, United Kingdom